FDAnews
www.fdanews.com/articles/134608-delcath-8217-s-liver-cancer-treatment-device-suffers-regulatory-setback

Delcath’s Liver Cancer Treatment Device Suffers Regulatory Setback

February 25, 2011
Medical research firm Delcath Systems Inc. has suffered a setback in bringing its liver cancer treatment to market.
Post Star